pharma · Eosinophilic esophagitis · Narcolepsy
Bioprojet
Bioprojet Pharma
Bioprojet patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
9 rue Rameau, Paris, 75002, FR HQ
166 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- 9 rue Rameau, Paris, 75002, FR
- Employees
- 166
- Programs
- 0
- Drugs
- 8
- Patents
- 3
Bioprojet patents
3 pharmaceutical patents indexed for Bioprojet. 0 expire within 24 months.
Bioprojet has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Bioprojet have?
3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Bioprojet patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.